Location
Live Online
Join the conversation on Twitter using #CatoHealth. Follow @CatoEvents on Twitter to get future event updates, live streams, and videos from the Cato Institute. If you have questions or need assistance registering for the event, please email our staff at events@cato.org.
When in November 2020 the Food and Drug Administration (FDA) proudly announced that it had approved the first at‐home self‐administered test for COVID-19, there was one catch: patients must get a prescription from a licensed health care practitioner (who is instructed to prescribe it only to symptomatic patients) to purchase and self‐administer the test. This not only defeats the purpose of an at‐home test but runs counter to the goal of restraining contagion.